CNCarolina Vásquez Narváez

Carolina Vásquez Narváez

*This is an algorithmically generated author record based on publicly available information.

Carolina Vásquez Narváez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Accidente cerebrovascular isquémico en un paciente VIH: neurosífilis y síndrome antifosfolípidos

    by Sebastián Ayala, María del Mar Ortiz, María Carolina Vásquez

    La infección por HIV es un factor de riesgo para el desarrollo de enfermedades cardiovasculares, incluyendo los accidentes cerebrovasculares isquémicos.Se presenta el caso de un hombre de 27 años con sida, con un accidente cerebrovascular isquémico de la arteria cerebral media izquierda. Los exámenes de laboratorio confirmaron el diagnóstico de neurosífilis y, además, confirmaron la existencia de anticuerpos antifosfolípidos. Siete meses después del tratamiento de la neurosífilis, de la anticoagulación y de la terapia antirretroviral, se confirmó la persistencia de anticuerpos antifosfolípidos.El enfoque diagnóstico de un accidente cerebral vascular en personas con HIV es un reto, ya que puede asociarse a múltiples etiologías. La relevancia de los anticuerpos antifosfolípidos en estos pacientes es tema de debate y debe tenerse en cuenta según el cuadro clínico.

  • Open Access

    Reframing West Nile Virus in Latin America: From Enzootic Evidence to Human Risk—Surveillance Gaps and One Health Actions

    by Juan S. Izquierdo-Condoy, Janeth C. Gil, Jhan. S. Saavedra-Torres, H. A. Nati-Castillo, Juan Jose Martinez Penaranda, Carolina Vásquez Narváez, Andrés López-Cortés, Marlon Arias-Intriago, Esteban Ortiz-Prado

    West Nile virus (WNV) is a mosquito-borne flavivirus with one of the widest global distributions. Since its discovery in Uganda in 1937, it has become a major zoonotic pathogen, and after its introduction into the United States in 1999, it spread rapidly across the Americas, becoming the leading cause of neuroinvasive arboviral disease. Its expansion illustrates a remarkable ecological adaptability, further intensified by climate change. In Latin America and the Caribbean, WNV circulation has been consistently documented in birds, horses, and mosquitoes; however, confirmed human cases remain disproportionately scarce compared with North America and Europe. Reports include sporadic human cases in Brazil (>100 since 2014), Mexico (~13), Argentina (2006–2007), Puerto Rico (2007), Nicaragua, and Haiti, while animal and vector evidence extends to Guatemala, El Salvador, Belize, Costa Rica, Bolivia, Paraguay, Colombia, Venezuela, Cuba, and Ecuador. This paradox likely reflects structural limitations within regional health systems, including underdiagnosis, restricted diagnostic capacity, and significant surveillance gaps, particularly in contexts where mild febrile syndromes may be misclassified as dengue, Zika, or Chikungunya. The regional risk of emergence is further amplified by climatic variability, ecological change, and intensifying human–wildlife interactions. Experiences from Europe highlight the importance of early detection, transfusion safety, and integrated surveillance within a One Health framework. Strengthening preparedness in Latin America will require investments in diagnostic infrastructure, implementation of standardized seroepidemiological surveys, development of predictive models tailored to local ecological contexts, and robust intersectoral collaboration.